Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Blinded Reading, Self Controlled, Superiority Priority Clinical Trial of Assisted Fundus Image Diagnosis Software for the Diagnosis of Multiple Eye Fundus Diseases

NCT04723160 is registered in ClinicalTrials.gov with Visionary Intelligence Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04723160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Blinded Reading, Self Controlled, Superiority Priority Clinical Trial of Assisted Fundus Image Diagnosis Software for the Diagnosis of Multiple Eye Fundus Diseases
Lead sponsor
Visionary Intelligence Ltd.
Phase
Observational
Overall status
Completed
Start date
August 10, 2020
Completion date
May 30, 2021
Enrollment
748 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

central serous chorioretinopathy, diabetic retinopathy, epiretinal membrane, exudative age related macular degeneration, macular holes, nonexudative age-related macular degeneration, optic atrophy, pathologic myopia, retinal artery occlusion, retinal detachment, retinal vein occlusion, retinitis pigmentosa, suspect glaucoma